Welcome to the Science of Mushrooms and Health website, an information resource for the latest credible scientific information on the health benefits of eating mushrooms.
The website’s central document is the Mushrooms and Health Report, a thorough review and evaluation of the state of the science linking mushrooms and health. Since the initial Report in 2008, Mushrooms and Health has been updated in 2010, 2012 and most recently in 2014. The Report is prepared under the direction of Peter Roupas, PhD, Commonwealth Scientific and Industrial Research Organisation (CSIRO; www.csiro.au ), Australia's largest and most diversified food research organization. Click on the Mushrooms and Health Report 2014 tab to read the Initiative’s “Crown Jewel.”
The Bulletin, a quarterly newsletter, keeps you current on the Initiative’s activities and includes abstracts of new research on mushrooms and health. The Bulletin is your primary resource for ideas on how countries communicate nutrition research to consumers through customized messages; and includes a special column, Mushrooms Get Social, with country-specific social and digital links. Click on the MHGI Bulletin tab for current and past archived issues. You can subscribe to the Bulletin by sending e-mail contact information to: firstname.lastname@example.org. To contact a mushroom association near you, click on the National Mushroom Associations tab.
You are welcome to contact us via email@example.com
NOTE: The Mushrooms and Health website provides links to other sites for your convenience and information. These Internet sites contain information created, published, maintained or otherwise posted by organizations independent of this site. Mushrooms and Health does not endorse, approve, certify or control these sites and does not guarantee the accuracy of the information contained on them.
A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer
Twardowski P et al. A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus–induced prostate-specific antigen responses. Article first published online: Cancer: 18 MAY 2015 DOI: 10.1002/cncr.29421. This study investigated the effects of white button mushroom (WBM) powder on serum PSA levels and determined the tolerability and biological activity of WBM. Thirty-six patients were treated; no dose limiting toxicities were encountered. The overall PSA response rate was 11% with two patients demonstrating complete response (PSA declined to undetectable levels). After 3 months of therapy, 13 (36%) patients experienced some PSA decrease below baseline. Therapy with WBM appears to both impact PSA levels and modulate the biology of biochemically recurrent prostate cancer by decreasing immunosuppressive factors.